what is your opinion on marijuana stocks?

Search

Member
Joined
Jan 19, 2005
Messages
3,248
Tokens
[h=1]More To Come For This Cannabis Lighting Company?[/h][FONT=wf_segoe-ui_normal]POSTED ON July 20, 2017 BY Jeremy Lutz[/FONT]
[FONT=wf_segoe-ui_normal]


Share6

Analysis originally distributed on July 13, 2017 By: Michael Vodicka of Cannabis Stock Trades
There are millions of square feet of cannabis cultivation facilities being built all across North America.
Take Americann (OTC:ACAN) for example. Americann is a U.S. based cannabis company headquartered in Massachusetts. Americann is in the early stages of building a 1 million square foot cultivation facility in Mass that will potentially serve as the primary cultivation hub to supply a huge portion of the Eastern cannabis market.
Cronos Group (CDNX:MJN.V) is another good example. Cronos is a Canadian cannabis company headquartered in Toronto. In May, Cronos announced that one of the companies it owns, Peace, had broke ground on a 315,000 square foot cultivation facility.
This project will include a 286,000 square foot production facility, a 28,000 square foot greenhouse, and a 1,200 square foot extraction laboratory.
When finished, this facility is expected to be one of the largest indoor cannabis production facility in the world.
As you can see, cannabis companies are in the process of hugely ramping up their cultivation capacities to meet the tidal wave of demand for cannabis coming down the pike.
One way to profit is to simply invest in the companies building these cultivation facilities. That could turn out to be extremely profitable.
However, I have an even better way to potentially profit.
This way – you can profit from almost every cultivation company in the entire industry by investing in a company that is already supplying cultivation centers with mission critical lighting systems.
Solistek Digital (OTC:SLTK) is an early leader in the high-growth industrial cannabis lighting systems industry. The company is headquartered in Carson, California and has a market cap of $51 million.
Solitek’s specialty is designing and manufacturing a wide range of lighting systems and components that are crafted specifically for the cannabis industry.
Its line of products range from complete lighting systems to individual bulbs.
Here is an example of the higher end, complete lighting system.
8725.jpg

Here is a list of features from the Solis Tek website showcasing how technologically advanced these systems are.

  • Professional 1000W adjustable ultra high frequency lighting system
  • High efficiency super reflective horticultural aluminum
  • Suitable for High Pressure Sodium & Metal Halide Lamps
  • Incredibly high output & even spread
  • Featuring Ignition Control™ & SenseSmart™ diagnostic check
  • Includes SolisTek high output 2,100 µmol HPS lamp
  • Light weight & easy to install & reflector is easily replaceable
  • These units range in price from $549 to $599
Here are a few pics of Solistek’s digital reflectors.
8726.jpg

Here are a few pics of Solistek’s digital light bulbs.
8727.jpg

[h=2]Solistek 2016 Revenue was up 11% from 2015[/h]Solistek is already establishing itself as an early leader in a high-growth cannabis sub industry. Its recent earnings reports have shown impressive growth.
It's 2016 revenue increased 11% from 2015 to $8.56 million.
Gross profit was up 15% to $3.12 million.
Gross Margins increased to 36.5% up from 35.3% in 2015.
Its cash balance increased 159% to $276,000.
More recently, Solistek reported awesome first-quarter results on May 8.
Revenue jumped 12% from the same period last year to $2.9 million.
Gross profit jumped 21% to $1.1 million. and $925,957, respectively.
Gross margin once again ticked higher, climbing to 38.6% from 35.8% in the first quarter of 2016.
Its cash balance was up big, climbing 50% to $416,000.
This growing cash balance is important because it gives Solistek more capital to invest in growth.
On a GAAP basis, which is how regulators require publicly traded companies report their quarterly results, net income was negative for the quarter.
However, on a non-GAAP basis when stripping out one-time expenses, Solistek was almost break even on profit for the quarter. That represents an important turning point that shows the company is on the verge of becoming profitable.
[h=2]Solistek is Getting More Attention in the Broader Cannabis Industry[/h]Solistek’s impressive growth is generating more interest within the cannabis industry.
In April, Solistek was added to the MJIC North American and United States Cannabis indices.
Solistek achieved multiple qualifiers to be included in the index.
The minimum trading requirements for companies to join the index are:

  • Co weighted average minimum market capitalization of US$30 million
  • Daily trading volume of US$600,000
  • Share price of US$0.10
This is an important achievement for Solistek because it will help the company gain more publicity from investors and that should eventually drive more capital inflows into its stock.
[h=2]Solistek Looks like one of the Most Undervalued Stocks in an Overvalued Industry[/h]Since this company isn’t yet profitable, we must use sales to analyze valuation.
Based upon first-quarter sales of $2.9 million, I am expecting Solistek to deliver sales of $12 million in 2017.
With a market cap of $50 million, that has Solistek trading at 4.2X annual sales.
A sales ratio of 3 is considered value territory. So a 4.2 multiple on a company growing revenue 12% year over year is a pretty nice bargain in the cannabis industry.
[h=2]Solistek is Developing Major Support on the Chart[/h]Solistek has had a pretty wild year on the chart.
Shares spent the first three months of the year trending higher. Then Solistek blasted higher above $3, giving it a 550% gain. Since then, shares have fallen sharply but are still up 175% on the year. Take a look below.
8728.jpg

This looks like a great formation to me. I think shares are in the early stages of forming a long-term bottom and should reverse and head higher.
[h=2]The Big Picture on Solistek[/h]Solistek is an early leader in the cannabis sub industry of lighting equipment. Sales growth has been impressive in the last 12 months, which has gotten the attention of the broader cannabis sector and led to its inclusion in the MJIC cannabis index. I’ve got this stock on my short list to add to the Cannabis Stock Trades member portfolio.
Enjoy,
7937.jpg
Michael Vodicka
Editor, Cannabis Stock Trades
Disclosure: Michael Vodicka owns shares of Terra Tech (TRTC), Kush Bottles (KSHB), Cara Therapeutics (CARA) and INSY Therapeutics (INSY)

[/FONT]
 

Member
Joined
Jan 19, 2005
Messages
3,248
Tokens
861dc0a71bd1cffa70aae5053e4a7336

Solis Tek (OTCQB: SLTK) Exclusive Webinar 8/10 at 1pm ET




This webinar meets 1 times.


  • Thu, Aug 10, 2017 1:00 PM - 2:00 PM EDT

Show in My Time Zone



861dc0a71bd1cffa70aae5053e4a8588
Learn more about how Solis Tek generates revenue in the Cannabis industry without ever touching the plant! Solis Tek Inc., (OTCQB: SLTK) a company focused on the research, design, development and manufacturing of advanced, energy efficient indoor horticulture lighting and ancillary equipment, generated sales in excess of $8.5mm in 2016. The company has continued growth in the core business and is… More gaining traction with its newly introduced specialized nutrients line developed to boost terpenes. To sign up for the Solis Tek (OTCQB: SLTK) webinar and to receive a recording if you can't make it, please fill out the registration form below. The speakers will include founder Alan Lien and new CEO Dennis G. Forchic, hosted by Alan Brochstein of New Cannabis Ventures. Less https://register.gotowebinar.com/register/439239886455386370
 

Member
Joined
Jan 19, 2005
Messages
3,248
Tokens
[h=1]Solis Tek Presentation Now Available for On-Demand Viewing[/h]


CNW GroupAugust 7, 2017


Comment

Company invites individual and institutional investors as well as advisors to log-on to VirtualInvestorConferences.com to view presentation
CARSON, Calif. , Aug. 7, 2017 /CNW/ -- Solis Tek (SLTK), a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products and solutions to commercial cannabis growers in legal markets across the U.S., today announced that the August 3 presentation from Dennis G. Forchik, Chief Executive Officer and Alan Lien , Co-Founder and President, is now available for on-demand viewing at VirtualInvestorConferences.com.
327291LOGO
<img alt="View investor presentations 24/7 at www.virtualinvestorconferences.com." class="Maw(100%)" src="https://s.yimg.com/bt/api/res/1.2/EgjP3jy40SRiDKewJyiFpw--/YXBwaWQ9eW5ld3M7c209MTt3PTgwMA--/http://globalfinance.zenfs.com/en_us/Finance/US_AFTP_CNWGROUP_CCM_LIVE/327291LOGO" itemprop="url"/>
View investor presentations 24/7 at www.virtualinvestorconferences.com.
More
LINK: https://tinyurl.com/0803postpr
Solis Tek's presentation will be available 24/7 for 90 days. Investors and advisors may download shareholder materials from the "virtual trade booth" for the next three weeks.
Recent Company Highlights

  • In July 2017 , Solis Tek announced that controlled third-party independent testing efforts have yielded results reflecting no heavy metals in Terpenez ™, the company's new terpene profile enhancer, verifying the product's safety profile for all agriculture uses.
  • In June 2017 , Solis Tek announced the launch of its Nutrient Line, which uses natural ingredients to help growers increase yield, enhanced aroma, and ultimately grow healthier plants.
Learn more about the event at www.VirtualInvestorConferences.com.
To be added to the distribution list, please email SLTK@kcsa.com with "SLTK" in the subject line.
About Solis Tek
Solis Tek is a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products and solutions to commercial cannabis growers in both the medical and adult use space in legal markets across the U.S. For nearly a decade, growers have used Solis Tek's digital lighting solutions to increase yield and lower costs and grow better. The Company's customers include retail stores, distributors and commercial growers in the United States and abroad. For more information please visit our website www.solis-tek.com.
 

Member
Joined
Jan 19, 2005
Messages
3,248
Tokens
[FONT=wf_segoe-ui_normal]Solis Tek, Inc. Announces Second Quarter 2017 Results[/FONT]
[FONT=wf_segoe-ui_normal]Aug. 14, 2017 8:30 AM[/FONT]
[FONT=wf_segoe-ui_normal]MarketwireCARSON, CA -- (Marketwired) -- 08/14/17 -- Solis Tek, Inc. (SLTK), a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products and solutions to commercial cannabis growers in legal markets across the U.S., today reported financial results for the quarter ended June 30, 2017.
Financial Highlights

  • Revenues of $2.44 million; up 15% over the same period in 2016
  • Gross Profit of $920 thousand; up 15% over the same period in 2016
  • Gross Margin of 37.7%; consistent with comparable period in 2016
Business Highlights

  • Launched Solis Tek's TERPENE ENHANCING Nutrient Line, TERPENEZ™, which uses natural ingredients to increase yield, lower costs and grow healthier plants
  • Introduced new lighting controller at end of 2nd quarter to consumer marketplace, providing industry leading control capabilities to commercial and recreational growers
"We are pleased with our second quarter results, showing solid growth from our core operations, highlighted by 15% year-over-year Q2 revenue growth from our lighting equipment vertical. We believe demand trends centered around terpene profile and strain desirability based on terpene profiles will support the launch of our heavy-metal-free Nutrient Line, and are confident that initiatives recently undertaken to raise the Company's visibility among key target audiences will drive enhanced growth opportunities for Solis Tek," commented Dennis G. Forchic, Chief Executive Officer of Solis Tek.
"We are executing Solis Tek's strategy to provide a broad suite of products and services through our wholly owned subsidiaries, targeted at the commercial cannabis industry. We're excited about the feedback we have received from the grower community regarding our new terpene enhancing product TERPENEZ, and are confident that the product will emerge as a preferred choice among cannabis growers because it has been verified in independent third-party testing to be free of heavy metals and safe for all agriculture uses, while producing unrivaled results regarding terpene profiles.
"By leveraging the same client base as our existing lighting products, we expect the launch of the new nutrient division to drive significant revenue growth for Solis Tek, while expanding margins due to the increased efficiencies derived from utilizing existing sales and distribution channels. Solis Tek remains ideally positioned to capitalize on the rapidly expanding legalization of medical and adult-use cannabis, supported by these industry leading product platforms," concluded Mr. Forchic.
Second Quarter 2017 Results
For the second quarter of 2017, revenues were $2.44 million, representing a 15% increase over the same period in 2016, driven by increased market penetration among hydroponic customers and commercial facilities. Cost of revenues increased 15%, consistent with revenue growth. Thus, gross margins were consistent year-over-year at 37.7%.
Selling, general, and administrative expenses were $2.39 million in the second quarter of 2017, up 212% over the same period in 2016, due primarily to cash and stock-based compensation expenses to support a broad campaign to increase Solis Tek's industry and investment community visibility and, to a lesser extent, increased marketing and payroll related expenses.
Stock compensation expense was $1.19 million for the second quarter of 2017, compared with $25,000 in the same period in 2016. Research and development expenses were $82,500, 42% higher than the same period in 2016.
Net loss for the second quarter of 2017 was $1.59 million, or $0.04 per share, compared with a net loss of $35,157, or $0.00 per share for the same period in 2016, again due primarily to cash and stock-based compensation expenses.
As of June 30, 2017, the Company had $428,000 in cash, 55% higher than $276,000 at December 31, 2016, attributable to $300,000 received through the issuance of common stock to accredited investors.
To be added to the Solis Tek email distribution list, please email SLTK@kcsa.com with SLTK in the subject line.
About Solis Tek
Solis Tek is a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products and solutions to commercial cannabis growers in both the medical and recreational space in legal markets across the U.S. For nearly a decade, growers have used Solis Tek's lighting solutions to increase yield, lower costs and grow better to maximize their return on investment. The Company's customers include retail stores, distributors and commercial growers in the United Statesand abroad. For more information, please visit our website, www.solis-tek.com.
Safe Harbor Statement
[/FONT]
 

my clock is stuck on 420 time to hit this bong
Joined
Sep 21, 2004
Messages
8,148
Tokens
Solis Tek makes a decent ballast but outside of that there are much better bulbs and reflectors out there. Alot of growers have been going led they run much cooler. biggest problem with hps and metal halide rooms heat up big time. LED is a lot friendlier on kilowatt per hour usage . As long as your getting the proper light lumens and your electric bill is not spiking growers are happier
 

Member
Joined
Jan 19, 2005
Messages
3,248
Tokens
Solis Tek makes a decent ballast but outside of that there are much better bulbs and reflectors out there. Alot of growers have been going led they run much cooler. biggest problem with hps and metal halide rooms heat up big time. LED is a lot friendlier on kilowatt per hour usage . As long as your getting the proper light lumens and your electric bill is not spiking growers are happier

Buy the stock. Its going up . They are doing a raise and looking at some very strong Acquisitions
 

Member
Joined
Oct 12, 2008
Messages
10,180
Tokens
technically , marijuana stocks are breaking. Long term, this is as a good as go as possible. In Canada, there is a GROSSLY liberal govt-- so far left, gotta be 2 standard deviations from normal. Trudeau 2 is a liberal's wet dream. Its a go in Canada for the summer of 2018.
 

Member
Handicapper
Joined
Sep 25, 2005
Messages
4,147
Tokens
marijuana stocks are the space where the the billion dollar VC play and Capital Investment Corporations, they buy the companies before they ever go public, Scotts Miracle-Gro Co is the simplest play
 

Member
Joined
Jan 19, 2005
Messages
3,248
Tokens
SOURCE: CFN Media
45587_CFNMedia.jpg

September 26, 2017 09:00 ET
Solis Tek Beats Out Competition in Cannabis Lighting Study -- CFN Media


SEATTLE, WA--(Marketwired - Sep 26, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article examining Solis Tek Inc. (OTCQB: SLTK) and a recent independent lighting study.
There's an estimated 1,600 to 2,200 wholesale cannabis cultivation businesses in the United States and over 1,000 dispensaries that grow their own cannabis, according to the Marijuana Business Factbook. Lighting systems are a vital part of any cultivation operation. They typically represent 20-30% of a commercial grower's overall startup cost. Choosing the right lighting technology can impact the quality of a grow and the yield a cultivator gets out his or her garden.
According to an independent, third-party test of six cannabis-focused lighting companies, Solis Tek Inc.'s (OTCQB: SLTK) digital lighting solutions scored the highest in terms of overall value for cultivators. Analysts expect the U.S. cannabis industry to exceed $50 billion in size over the coming years, following the legalization of recreational marijuana in states like California and Nevada, which creates an enormous opportunity for lighting providers.
Light Laboratory Study
Light Laboratory Inc., an independent photometric testing laboratory, evaluated six different cannabis lighting providers to assess which offered the best overall value for cultivators. The study evaluated photosynthetic photon flux density ("PPFD"), which measures the quantity of light that arrives at the plant canopy and how plants "see" and "absorb" light. Higher readings translate to improved plant yields and lower costs for cultivators.
The study found that Solis Tek's All-In-One A1 fixture had the best light output, providing a high-intensity and a more consistent footprint than competing options. In other words, the lighting solutions help commercial growers avoid hotspots and create a more even canopy, where no one plant grows taller and overshadows other plants. This helps anyone interested in growing cannabis plants create the best environment to increase yield.
Solis Tek's unique four spectrum "light diet" targets specific growth cycles and replicates the different seasons of the year, where the plants make use of natural light in different ways. The company was the first cannabis lighting company to offer these features, which are now standard among many top commercial cannabis growers. These attributes help cultivators produce the highest quality crops at the lowest prices for consumers.
A Growing Opportunity
Solis Tek has experienced tremendous growth over the past several quarters as it capitalizes on increasing demand for its lighting solutions. In addition to its lighting products, the company recently expanded into the nutrients business with the launch of TERPENEZ™ in an effort to increase revenue and expand profit margins by upselling its existing customers. These efforts could unlock even more value for shareholders over the long-term and potentially improve its valuation multiples as it enters the $32 billion nutrient/additive sector.
Last quarter, the company reported revenue that increased 14.8% to $2,441,289 and a gross profit of $919,879. The company also introduced a new lighting controller at the end of the second quarter. These developments could support further revenue growth throughout the remainder of the year given the synergies with its existing customers and product lines.
"By leveraging the same client base as our existing lighting products, we expect the launch of the new nutrients division to drive significant revenue growth for Solis Tek, while expanding margins due to the increased efficiencies derived from utilizing existing sales and distribution channels," says CEO Dennis Forchic. "Solis Tek remains ideally positioned to capitalize on the rapidly expanding legalization of medical and adult-use cannabis."
Please follow the link to read the full article: http://www.cannabisfn.com/solis-tek-beats-competition-cannabis-lighting-study/
 

Member
Joined
Jan 19, 2005
Messages
3,248
Tokens
A Little-Known Standout With Huge Potential Upside

There are still some small companies that have yet to be discovered by Wall Street. Solistek (SLTK) could be one of these exceptions, and this stock may offer triple-digit upside to investors should the company continue to grow revenue as the marijuana industry takes off, and if investors start to take notice of this undiscovered name.
Solis Tek provides high-quality lighting equipment and supportive nutrients to the marijuana industry, with revenues of $8.5 million last year. Gross profit was over $3 million, and the company just announced that revenue in the second quarter of this year grew a rapid 15% over the same quarter in 2016. Their products are sold by over 500 re-sellers in the U.S., Canada, and parts of Europe, and the company even won Dope Magazine's Best Lighting Company Award in 2016. SLTK's management own about 75% of the company's stock, which means they are highly incentivized to maximize value to shareholders - themselves included.
Here's what makes it a standout - while the above companies are trading at high multiples of their recent sales figures, SLTK is still undiscovered. Applying a 15x sales multiple to SLTK's $8.5 million in 2016 revenue, like that of MCIG, would imply a potential share price of $3.40 if the market started to pick up on this price disparity.
Discovering price disparities is exactly how smart traders make their profit, and we think SLTK's execution in 2017 could justify major price appreciation as Wall Street picks up on this supplier.
https://finance.yahoo.com/news/why-cannabis-stocks-still-poised-120000082.html
 

New member
Joined
Oct 13, 2006
Messages
17,245
Tokens
I got some RX'ers into Aphria and Aurora, Canadian firms. We're up nicely on the two. Got one laggard, Cara Therapeutics, but I'm more than comfortable holding the stock. If you aren't holding weed, missing the boat. Pain management is the next frontier, they're gonna kill the fat hog.

~T~
 

Member
Joined
Jan 19, 2005
Messages
3,248
Tokens
Solis Tek, Inc. Enhances its Digital Lighting Product Offerings; Introduces Controller to Enable Commercial Growers to Take Complete Control of Lighting Environment






MarketwiredOctober 17, 2017









(no caption)Click here for high-resolution version
More

CARSON, CA--(Marketwired - October 17, 2017) - Solis Tek (SLTK), a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products and solutions to commercial cannabis growers in legal markets across the U.S., announced today the availability of its lighting controller, which enables commercial growers to harness more control of its garden's lighting environment.
"For nearly a decade, Solis Tek has led innovation in the cannabis lighting sector," said Dennis G. Forchic, Chief Executive Officer of Solis Tek. "The controller is the next step in our lighting evolution, enabling growers to take more control and customize their growing experience, which in turn increases yield, ROI and enables them to grow better."
The Solis Tek Controller works with up to 300 lights at once and allows growers to manage multiple lighting cycles, located in different rooms/locations. Additional features include:

  • Precise canopy temperature monitoring that can be connected to up to 25 sensors
  • Customized sunrise and sunset options, enabling growers to run lighting cycles based on their plants' unique needs
  • Data analytics that track a garden's events
  • High temperature auto dim and shut off that automatically reacts based on room temperature
  • Energy efficient cloud cover to mimic the true nature of the sun when full intensity light is not needed
Today, Solis Tek is recognized as a leading innovator in the cannabis lighting sector with the world's top commercial growers utilizing the Company's HID (high-intensity discharge) lights. Solis Tek was the first company to provide Ignition Control, which is designed to prevent surges and breaker overloads by igniting lamps one at a time based on load stability, and SenseSmart, which is a pre-ignition diagnostic check to ensure that the lighting system is safe and working properly.
Forchic continued, "The controller provides a level of versatility not found in any other product on the market, specific to cannabis or others crops. For example, if a grower wishes to run their lights on a 22-hour cycle versus a 24-hour cycle that is possible. Or, if their plants do not need a full intensity light during a particular period, they can create an environment which mimics a cloud passing by."
To be added to the Solis Tek email distribution list, please email SLTK@kcsa.com with 'SLTK' in the subject line.
About Solis Tek
Solis Tek is a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products and solutions to commercial cannabis growers in both the medical and recreational space in legal markets across the U.S. For nearly a decade, growers have used Solis Tek's lighting solutions to increase yield, lower costs and grow better to maximize their return on investment. In 2017, Solis Tek introduced an organic nutrient line. The Company's customers include retail stores, distributors and commercial growers in the United States and abroad. For more information, please visit our website, www.solis-tek.com.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the Company's current plans and expectations, as well as future results of operations and financial condition. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Image Available: http://www.marketwire.com/library/MwGo/2017/10/17/11G146602/Images/MultimediaAsset1-1622609416.jpg







 

Member
Joined
Jan 19, 2005
Messages
3,248
Tokens
SLTK https://rumbletalk-images-upload.s3...8911efbf147abe6bfb/1509541847-sltk oct v2.rtf

The Biggest Marijuana Deal In Years Validates Little SLTK’s Upside Potential

Investors See Big Validation In Latest Cannabis Deal, SLTK Could Trade To Multiples Of Current Price

• Constellation Brands (NYSE:STZ) (NYSE:STZ.B) takes CAD$245mln, 10% stake in marijuana grower Canopy Growth (CA:WEED)(OTC:TWMJF), validating this emerging industry.
• Fortune 500 companies are looking to participate, and they’re putting money to work in companies that are executing on their businesses with real revenue and growth potential.
• SLTK has been growing revenue consistently in this vertical, and with increased validation the stock is poised for huge upside to catch up to peers. P/S comparison suggests multiples of possible upside through price discovery.

Beverage supplier Constellation Brands (NYSE:STZ) (NYSE:STZ.B), the owner of Corona and one of the largest suppliers of alcoholic drinks in the U.S. and Canada, just took a tremendous CAD$245 mln (US$190 mln) stake in Canopy Growth Corp. (TSE:CGC) (OTCMKTS:TWMJF) (CA:WEED) in order to own 9.9% of the company. This values Canopy Growth at over 61x their fiscal 2017 sales, and 38x this year’s estimated sales, an encouraging figure for other companies operating in this space.

But the investment goes far beyond just an interest in the company. Canopy Growth and Constellation will work intimately on consumer analytics, marketing and branding, as well as collaborate on the development and marketing of future cannabis-based beverages.

The biggest deal in cannabis in years demonstrates just how great the appetite is for this blossoming industry among larger companies. Investors have just begun to see the investments and partnerships that large companies will be inking in the next decade, which sets up quality companies that are executing on their businesses, like Solis Tek Inc (OTCMKTS:SLTK), for potentially big upside.

This is exceptional validation of this blossoming industry, but it’s not the first of its kind. We’ve seen Scotts Miracle-Gro (NYSE:SMG) make a concerted push into the marijuana space as well through its Hawthorne subsidiary, which is focused on hydroponics and similar growth mediums. The company has made consistent investments, totaling more than $200 mln in a few years, in the lighting, materials, and supplies that support cannabis growers like Canopy Growth Corp.

Clearly, large companies see the future of cannabis. Investors should be positioning the same way.

Why Canopy Growth And Why Now?

The answer is growth and quality execution. First and foremost the market opportunity is immense. Legal marijuana, for medicinal or recreational use, generated $7 billion in the U.S. in 2016. Analysts at Cowen and Company expect that to grow to $25 billion by 2020, and $50 billion by 2026. State laws are lining up in that direction with almost half of the country having legalized cannabis in one form or another as of fall 2017.

Second, Canopy Growth is executing well on their business plan and generating revenue, unlike many other small companies in the industry. Canopy brought in almost $40 million in revenue through the summer of this year, and the growth has been steady with improving gross margins. Canopy is steadily proving that they’re a real player and here to stay, and the large Constellation investment speaks to that.

Execution is key, and investors have noticed. TWMJF is up 160% in the last 12 months.

Or take Aurora Cannabis Inc. (OTC: ACBFF), for instance, which also trades on Toronto’s venture exchange and is another company focused on growing and selling medical marijuana. The stock delivered huge 312% gains in 2016 and has done an excellent job of monetizing their business in the last two years: Aurora delivered $18 million in sales so far in 2017.

Quiet SLTK Has Been Executing, Stock Ready to Explode Higher With Innovation
Solis Tek has been executing extremely well in this market, credited with some of the biggest innovations in the cannabis grow light space over the last 5 years and growing revenue. Grow lighting is an overlooked but HIGHLY lucrative space. The global cannabis grow light market is expected to reach $8.6 billion by 2025 according to Grand View Research.
Solis Tek’s digital ballast, for example, was designed with Ignition Control™ sequential lamp ignition and self-diagnostic safety systems to ensure everything is running smoothly and efficiently. That's resulted in some high-profile customers, including GB Sciences (OTCQB:GBLX), three-time US Cannabis Cup winner for Best Flowers Kyle Kushman, and Colin Gordon of Ethos Genetics.
In fact, a third party independent test of six lighting products serving the commercial cannabis sector conducted by Light Laboratory Inc confirmed that Solis Tek's digital lighting solutions scored highest in terms of overall value for cultivators. Grow lights are critical to facilitating the growth of healthier plants throughout the growth cycle. Some products are better not only because they enhance the growth capabilities, like SLTK's, but also because they can conserve energy when used correctly.
With nearly $2.5 million in sales last quarter alone, SLTK offers a rare pure-play opportunity in the cannabis industry. The company’s $10 million potential run-rate this year, with gross margins of 37%, are rare in this emerging industry. SLTK could be approaching profitability in the very near-term with the right sales growth, and the opportunity is a big one - Grand View Research expects a CAGR in the growth light space of 14%! And most recently, the company has diversified, launching a terpene-enhancing nutrient line called Terpenez, which uses all-natural ingredients to increase yield, lower cost, and grow healthier plants.
SLTK is rapidly creating a one-stop, top-quality provider for cannabis cultivators. And they're doing so without ever touching the plant, reducing the direct risk associated with federal law.
Finally, SLTK trades at a very conservative valuation based on our 2017 estimate of approximately $10 million in revenue, or a Price/Sales ratio of 4x. Compare that to the P/S of Canopy Growth, which has now reached 66x based on CAD$39.8 mln in their fiscal 2017. A move of even half this magnitude to trade in line with this peer would value SLTK at over $5.00, and we think a revaluing higher is not out of the question quickly with continued execution on the part of SLTK.
 

Member
Joined
Jan 19, 2005
Messages
3,248
Tokens
Solis Tek Announces Closing of $2.5 Million Financing






MarketwiredNovember 13, 2017






ARSON, CA--(Marketwired - November 13, 2017) - Solis Tek (SLTK) ("Solis Tek" or "Company"), a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products and solutions to commercial cannabis growers in legal markets across the U.S., announced today the Company has closed on its recent round of financing by securing $2.5 million of which $1.75 million came through a secured convertible debenture with a single institutional investor.
Solis Tek's Chief Executive Officer Dennis G. Forchic, stated, "We are pleased to have secured funding that will enable Solis Tek to capitalize on the robust commercial opportunity that lies before us. The proceeds will enable the Company to assure our supply chain execution and maintain inventory levels that can meet customer demand for our industry-leading lighting products. In particular, we are excited to ramp commercial activities, fulfill initial orders, and build inventory for our recently-launched Controller, which enables growers to customize their growing experience by mimicking the conditions of natural sunlight, and to automate production for our Nutrient Line, from which we soon plan to launch our second commercial product."
For more information on the financing, please read the 8-K which was filed and posted at www.sec.gov.
About Solis Tek
Solis Tek is a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products and solutions to commercial cannabis growers in both the medical and adult use space in legal markets across the U.S. For nearly a decade, growers have used Solis Tek's digital lighting solutions to increase yield, lower costs and grow better. The Company's customers include retail stores, distributors and commercial growers in the United States and abroad. For more information please visit our website www.solis-tek.com.
 

Member
Joined
Jan 19, 2005
Messages
3,248
Tokens
November 14, 2017


Comment

CARSON, CA--(Marketwired - November 14, 2017) - Solis Tek Inc. (SLTK), a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products and solutions to commercial cannabis growers in legal markets across the U.S., today reported financial results for the quarter and nine month period ended September 30, 2017.
Financial Update

  • Third Quarter 2017 revenues of $1.99 million; up 6% over the same period in 2016
  • Revenues of $7.34 million for the first nine months of 2017; up 11.4% over the same period in 2016
  • Third Quarter 2017 gross profit of $671 thousand; up 5% over the same period in 2016
  • Gross profit of $2.71 million for the first nine months of 2017; up 14.5% over the same period in 2016
Business Update

  • Successful launch of proprietary Digital Lighting Controller to unprecedented market response and demand
  • Testing initialized for second Zelda Horticulture, Inc. nutrient product
  • Independent, third party test of six lighting companies scored Solis Tek's Digital Lighting solution highest in terms of overall efficiency and value for cultivators
Subsequent Event

  • In November, 2017, Solis Tek closed on a financing that provided $2.5 million in new capital to support supply chain fulfillment and nutrient line automation
"We've significantly expanded our product portfolio in the third quarter and the increased demand for our products has continued," commented Dennis G. Forchic, Chief Executive Officer of Solis Tek. "We are particularly excited about the response to our new Digital Lighting Controller. This device complements our existing upgraded product line and enables cultivators to schedule and monitor their grow rooms, thus increasing the grower's yield and ROI. Initial demand for the Controller exceeded expectations. With the recent funding round now complete we are excited to be able to increase inventory levels across the board to meet projected demands."
Mr. Forchic continued, "With the successful completion of our recently announced financing transaction that resulted in more than $2 million in capital, Solis Tek is well positioned to realize sustained supply chain execution, thus maintaining healthy inventory levels of key products across our product portfolio to support continued revenue growth. We also plan to use the proceeds from this financing to automate production of our Nutrient Line, which is rapidly moving towards introducing its second commercial product. We remain excited by the demand trends we are seeing across both our lighting and nutrient units, which will leverage the same distribution-supply channels and client base, spearheading our planned drive toward significant revenue growth and expanded margins for Solis Tek. We see tremendous opportunity for Solis Tek as we position the Company for dynamic growth in 2018 and beyond."
Financial Results for the Quarter Ended September 30, 2017
For the third quarter of 2017, revenues were $1.99 million, representing a 6% increase over the same period in 2016. These increases were driven by increased market penetration among hydroponic customers and commercial facilities. Cost of revenues increased 7% over the same period in 2016, modestly lowering gross margin to 33.7%, compared with 34.1% for the same period in 2016.
Selling, general, and administrative expenses were $2.05 million in the third quarter of 2017, up 167% over the same period in 2016, due primarily to cash and stock-based compensation expenses to support a broad campaign to increase Solis Tek's industry and investment community visibility and, to a lesser extent, increased marketing and payroll related expenses.
Stock compensation expense was $556,000 for the third quarter of 2017, compared with $25,000 in the same period in 2016. Research and development expenses were $82,500, 42% higher than the same period in 2016.
Net loss for the third quarter of 2017 was $1.49 million, or $0.04 per share, compared with a net loss of $173,460, or $0.01 per share for the same period in 2016, again due primarily to cash and stock-based compensation expenses.
As of September 30, 2017, the Company had $194,000 in cash, compared with $276,000 at December 31, 2016.
Financial Results for the Nine Month Period Ended September 30, 2017
For the nine months ended September 30, 2017, revenues were $7.34 million, representing an 11.4% increase over the same period in 2016. These increases were driven by increased market penetration among hydroponic customers and commercial facilities. Cost of revenues increased 9.6% over the same period in 2016, resulting in gross margin of 37%, up from 35.9% for the same period in 2016.
Selling, general, and administrative expenses were $9.21 million in the nine months ended September 30, 2017, up 303% over the same period in 2016, due primarily to cash and stock-based compensation expenses to support a broad campaign to increase Solis Tek's industry and investment community visibility and, to a lesser extent, increased marketing and payroll related expenses.
Stock compensation expense was $5,361,046 for the nine months ended September 30, 2017, compared with $86,000 in the same period in 2016. Research and development expenses were $247,770 in the nine months ended September 30, 2017, 44% higher than the same period in 2016.

Net loss for the nine months ended September 30, 2017 was $6.83 million, or $0.18 per share, compared with a net loss of $163,657, or $0.01 per share for the same period in 2016, again due primarily to cash and stock-based compensation expenses.
To be added to the Solis Tek email distribution list, please email SLTK@kcsa.com with SLTK in the subject line.
About Solis Tek
Solis Tek is a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products and solutions to commercial cannabis growers in both the medical and recreational space in legal markets across the U.S. For nearly a decade, growers have used Solis Tek's lighting solutions to increase yield, lower costs and grow better to maximize their return on investment. The Company's customers include retail stores, distributors and commercial growers in the United States and abroad. For more information, please visit our website, www.solis-tek.com.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the Company's current plans and expectations, as well as future results of operations and financial condition. The Company undertakes no obligation to publicly update or revise any forward looking statements, whether as a result of new information, future events or otherwise.
Solis Tek Inc.
Condensed Consolidated Balance Sheets
September 30,
2017
December 31,
2016
(Unaudited)
ASSETS
CURRENT ASSETS
Cash$194,129$275,783
Accounts Receivable, net of allowance for doubtful accounts of $381,937 and $359,395865,429628,691
Inventories1,769,6382,880,804
Prepaid expenses and other current assets229,00475,109
Total current assets3,058,2003,860,387
Property and equipment, net155,025204,936
Other assets37,15432,071
TOTAL ASSETS$3,250,379$4,097,394
LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES
Accounts payable and accrued expenses$939,628$552,057
Due to related party vendor398,6561,083,764
Note payable - related parties545,000265,000
Amount due to related parties160,153134,086
Capital lease obligations, current portion12,87113,711
Loans payable, current portion7,9148,262
Total Current Liabilities2,064,2222,056,880
Capital lease obligations, net of current portion2609,665
Loans payable, net of current portion20,15925,958
Notes payable related parties, net of current portion600,000600,000
Total liabilities2,684,6412,692,503
Commitments and contingencies
Shareholders' Equity
Preferred stock, no par value, 20,000,000 shares authorized; no shares issued and outstanding--
Common stock, $0.001 par value, 100,000,000 shares authorized; 37,959,534 and 29,721,998 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively37,95929,722
Additional paid-in-capital8,778,6512,795,842
Accumulated deficit(8,250,872)(1,420,673)
Total Shareholders' Equity565,7381,404,891
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY$3,250,379$4,097,394

Solis Tek Inc.
Condensed Consolidated Statements of Operations
Three months ended
September 30,
Nine months ended
September 30,
2017201620172016
(Unaudited)(Unaudited)
Sales$1,993,865$1,877,000$7,336,980$6,587,498
Cost of goods sold (1)1,322,4971,236,5364,625,2104,219,412
Gross profit671,368640,4642,711,7702,368,086
Operating expenses
Selling, general and administrative expenses2,050,189767,2399,206,0762,286,464
Research and development82,50057,500247,770172,500
Total operating expenses2,132,689824,7399,453,8462,458,964
Loss from operations(1,461,321)(184,275)(6,742,076)(90,878)
Interest expense, net of interest income(28,190)(26,885)(84,010)(77,279)
Interest income---4,500
Loss before income taxes(1,489,511)(211,160)(6,826,086)(163,657)
Provision (benefit) for income taxes-(37,700)4,113-
NET LOSS$(1,489,511)$(173,460)$(6,830,199)$(163,657)
BASIC AND DILUTED LOSS PER SHARE$(0.04)$(0.01)$(0.18)$(0.01)
WEIGHTED - AVERAGE COMMON SHARES OUTSTANDING BASIC AND DILUTED37,079,97229,659,49837,482,50829,623,868
(1) Included in cost of goods from related party$977,784$723,387$3,607,090$3,309,941
https://finance.yahoo.com/news/solis-tek-inc-announces-third-120500802.html




 

Forum statistics

Threads
1,109,030
Messages
13,456,782
Members
99,448
Latest member
c54giving
The RX is the sports betting industry's leading information portal for bonuses, picks, and sportsbook reviews. Find the best deals offered by a sportsbook in your state and browse our free picks section.FacebookTwitterInstagramContact Usforum@therx.com